PET tracer C-11 4DST outperforms FDG in detecting cell proliferation

01/2/2012 | AuntMinnie.com (free registration)

The PET imaging agent C-11 4DST performed better than the standard PET agent FDG in detecting proliferation of cancer cells in patients with nonsmall-cell lung cancer, according to a Japanese study presented at a radiology meeting. PET/CT imaging with C-11 4DST can also allow for a noninvasive view of DNA synthesis in the disease, the researchers said. The C-11 4DST tracer can help differentiate between benign and malignant tissues, determine tumor activity, assess response to treatment and improve prediction of patient prognosis, a researcher said.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY